Phase I study of c-Met inhibitor ARQ197 in combination with FOLFOX for the treatment of patients with advanced solid tumors.
Suzanne Fields Jones
No relevant relationships to disclose
Carla Kurkjian
No relevant relationships to disclose
Manish R. Patel
No relevant relationships to disclose
Jeffrey R. Infante
No relevant relationships to disclose
Howard A. Burris
No relevant relationships to disclose
F Anthony Greco
No relevant relationships to disclose
Michael Brian Hemphill
Honoraria - Bayer; Eisai; Novartis
Adil I. Mohyuddin
No relevant relationships to disclose
Dana Shelton Thompson
No relevant relationships to disclose
Patrick Murphy
No relevant relationships to disclose
Eric Raefsky
No relevant relationships to disclose
Johanna C. Bendell
No relevant relationships to disclose